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Supplementary Materials and Methods

Synthesis of Gd(III)-labeled Molecules
Tris-Hydroxypropyl Triazolyl Amine (THPTA) and Tris-Benzyl Triazolyl Amine (TBTA) used as stabilizing and solubilizing ligands for copper(I) during click reactions were synthesized and purified according to literature procedure. 1, 2 Gd(HPN 3 DO3A) used in the synthesis of 1-7 was synthesized using previously published procedures. 3 1,4,7-(Tris-tert-butyl acetate)-1,4,7,10-tetraazacyclodecane•HBr (tertbutyl DO3A) used in the synthesis of 8-11 was synthesized as previously described. 4 The HPLC mobile phases consisted of deionized water (Solvent A) and HPLC-grade acetonitrile (Solvent B). Where applicable, a Waters 4.6 x 150 mm X-Bridge analytical C18 5 µm column and the semi-preparative equivalent, 19 x 150 mm were used. Solvents used with this column consisted of aqueous ammonium hydroxide, pH = 10.37 (Solvent C) and HPLC-grade acetonitrile (Solvent D).
Synthesis of 1
To a 250 mL round bottom flask was added water (25 mL), [Gd(HPN 3 DO3A)(H 2 O)] (0.150 g, 0.25 mmol) and Cu(II)SO 4 • 5 H 2 O (0.006 g, 0.025 mmol). To the stirring mixture was added tetrahydrofuran (24 mL). To a 2 mL glass vial was added tetrahydrofuran (1 mL), 1-hexyne (0.041 g, 0.50 mmol), and trisbenzyltriazolylamine (0.016 g, 0.03 mmol). The tetrahydrofuran containing the dissolved 1-hexyne and TBTA was then added to the stirring mixture of [Gd(HPN 3 DO3A)(H 2 O)] and Cu(II)SO 4 • 5 H 2 O. To this was added sodium ascorbate (0.05 g, 0.25 mmol) and the mixture was left to stir under nitrogen overnight at room temperature. The crude mixture was purified by semipreparative reverse phase HPLC using the following conditions 
Synthesis of 2
To a 250 mL round bottom flask was added water (75 mL) and [Gd(HPN 3 DO3A)(H 2 O)] (0.150 g, 0.25 mmol), Cu(II)SO 4 • 5 H 2 O (0.006 g, 0.025 mmol) and tris-hydroxypropyltriazolylamine (0.013 g, 0.03 mmol). With dissolution of these components was then added tert-butanol (24 mL). To a separate, 2 mL glass vial was added tert-butanol (1 mL) and 4-pentyne-1-ol (0.042 g, 0.50 mmol). 
Synthesis of 3 pent-4-yn-1-yl dihydrogen phosphate (3a):
To an oven-dried 50 mL round bottom flask was added a magnetic stir bar and anhydrous diethyl ether (25 mL). To the stirring solvent was added 4-pentyne-1-ol (0.452 g, 6.57 mmol), triethylamine (0.665 g, 6.57 mmol), and pyridine (1.039 g, 13.14 mmol). To a second, oven-dried 100 mL round bottom flask was added anhydrous diethyl ether (25 mL) and phosphorous oxychloride (1.211 g, 7.90 mmol). The flask containing phosphorous oxychloride was cooled to 0 °C with stirring, at which time was added dropwise the solution of 4-pentyne-1-ol over two hours, whereupon the mixture became cloudy with a visible white suspension. After the complete addition of 4-pentyne-1-ol solution, the reaction mixture was allowed to warm to room temperature and remain stirring for a further 12 hours. The pale brown mixture was then cooled again to 0 °C open to the atmosphere, and water (5 mL) was added and the reaction left to stir for one hour. To the stirring biphasic mixture was added 10 mL of 1M NaOH (aq), followed by separation of the organic phase using a separatory funnel and further extraction of the aqueous layer using additional diethyl ether (2 x 10 mL). To the isolated aqueous mixture was then added 15 mL of 1M HCl (aq), followed by extraction with ethyl acetate (3 x 10 mL). Successful synthesis and isolation of the product in the ethyl acetate was confirmed by ESI-MS of the phosphorylated product (m/z): observed: 162. 
Synthesis of 7
To a 250 mL round bottom flask was added water (25 mL 
Synthesis of 8
DO3A-tris-tert-butyl ester•HBr was synthesized according to previously published procedures. 4 An aqueous trifluoroacetic acid (TFA) solution, 30:1:1 (TFA:triethylsilane:H 2 O) was added and stirred at room temperature overnight to deprotect the ligand. TFA was removed from the solution by purging with a stream of nitrogen and concentrating from water twice. 1 equivalent of Gd(CH 2 COO) 3 •xH 2 O was added and the pH of the solution adjusted with 1M NaOH and 1M HCl to 6.5. The resultant was stirred at 60 °C overnight. The crude mixture was purified by semipreparative reverse phase HPLC.
Synthesis of 9
N-(tert-butoxycarbonyl)-3-hydroxypropylamine (9b): Di-tert-butyl dicarbonate (3.046 g, 13.9 mmol) was dissolved in 50 mL of tetrahydrofuran (THF). 3-amino propanol (9a, 1.062 mL, 13.9 mmol) suspended in 50 mL of THF was then added and the reaction stirred at room temperature overnight. The reaction mixture was concentrated under reduced pressure and the crude material purified by flash column chromatography over silica gel with 1:9 methanol:dichloromethane (MeOH:DCM) to afford a pale yellow oil (2.425 g, 99%). 
N-(tert-butoxycarbonyl)-3-bromopropylamine (9c):
Triphenylphosphine (1.553 g, 5.9 mmol) was dissolved in 30 mL of dichloromethane and cooled to 0 °C. triethylamine (0.830 mL, 5.9 mmol) was added via syringe. Bromine (0.305 mL, 5.9 mmol) diluted in 20 mL of DCM was added via syringe and the reaction vessel stirred at 0 °C for 1 hr. Upon warming to room temperature, 9b (0.852 g, 5.4 mmol) suspended in 10 mL of DCM was added via syringe. The reaction mixture was stirred at room temperature overnight. Upon concentration under reduced pressure, the crude reaction was purified by flash column chromatography over silica gel with 1:5 ethyl acetate/hexanes (EtOAc:Hex) to give a yellow oil (0.713 g, 3.2 mmol, 60% 4 mmol) at room temperature. The resultant was stirred at room temperature overnight. Complete deprotection was observed after 18 hours. TFA was removed from the solution by purging with a stream of nitrogen and concentrating from water twice. Upon resuspension in 20 mL H 2 O, Gd(III) acetate hydrate [Gd(CH 3 CO) 3 •xH2O, 0.118 g, 0.4 mmol) was added and the pH of the solution adjusted with 1M NaOH and 1M HCl to 6.5. The resultant was stirred at 60 °C overnight. The crude mixture was purified by semipreperative HPLC on a reverse phase C18 column, eluting using the following method: initial conditions of 0% B were held constant for 6 min, ramp to 12% B over 3 min, wash at 100 % B for 5 min followed by return to 0% B. The product fractions (8.43-11.00 min by UV/vis at 200 nm and 210 nm) were collected and freeze-dried (0.122 g, 0.2 mmol 62 %). Analytical LC-MS showed a single peak with m/z = 558.6; ([M + H] + ). 
N-(tert-butoxycarbonyl)-12-hydroxydodecylamine (11c):
Boc-lauric acid (11b, 1.005 g, 3.2 mmol) was dissolved in 25 mL of tetrahydrofuran. Red-Al [70% (w/w) in toluene, 2.7 mL, 9.5 mmol] was added dropwise via syringe over 10 minutes at room temperature. The reaction mixture was stirred for thirty minutes after the precipitant dissolved (approximately 2 hrs total). At this point, the reaction was quenched with a saturated solution of Na 2 SO 4 (aq) followed by stirring for an additional 1 hour at room temperature. The resultant solution was concentrated under reduced pressure, resuspended in ethyl acetate, washed with water, dried over MgSO4, filtered, and concentrated. Recrystallizaton with toluene afforded a crystalline, colorless solid (0.663 g, 2.2 mmol, 86% N-(tert-butoxycarbonyl)-12-bromododecylamine (11d): Triphenylphosphine (0.488 g, 1.9 mmol) was dissolved in 10 mL of dichloromethane and cooled to 0 °C. Triethylamine (0.260 mL, 1.9 mmol) was added via syringe. Bromine (0.100 mL, 1.9 mmol) diluted in 15 mL of DCM was then added via syringe and the reaction vessel maintained at 0 °C for 1 hour. Upon warming to room temperature, 11c (0.5067 g, 1.7 mmol) in 6 mL of DCM was added and the reaction vessel stirred at room temperature overnight. Reaction progress was monitored by thin layer chromatography. The reaction volume was concentrated under reduced pressure followed by flash column chromatography purification of the crude material with ethyl acetate:hexanes (5:1) to give a colorless, crystalline solid (0.411 g, 1.1 mmol, 67%) . Alternatively, the pure material can be obtained from recrystallizaton with acetonitrile. 3 mmol) at room temperature. The resultant was stirred at room temperature overnight. Deprotection was observed after 24 hours. TFA was removed from the solution by purging with a stream of nitrogen and concentrating from water twice. Upon resuspension in 20 mL H2O, Gd(CH 2 COO) 3 •xH 2 O (0.104 g, 0.3 mol) was added and the pH of the solution adjusted with 1M NaOH and 1M HCl to 6.5. The resultant was stirred at room temperature until pH was maintained at 6.5. The crude mixture was purified by semipreperative HPLC on a reverse phase C8 Sunfire column, eluting using the following method: : initial conditions of 5% B were held constant for 5 min, then a ramp to 100% B over 20 min, a wash at 100 % B for 4 min followed by return to 5% B. The product fractions (11:45-16:45 mins by UV/vis at 200 nm and 220 nm) were collected and freeze-dried (0.055 g, 0.08 mmol, 27%). Analytical LC-MS showed a single peak with m/z = 684.2 ([M + H] + ).
Magnevist [Gd(DTPA)(H 2 O)] (12)
Diethylenetriaminepentaacetic acid gadolinium(III) dihydrogen salt hydrate was purchased from SigmaAldrich (Catalogue number 381667) and used as supplied. To make up a solution, Milli-Q water was added and the pH was adjusted to 7 using 2.0M NaOH.
Synthesis of 13
Magnevist-NH 2 (13) was synthesized following previously published procedures developed by our group. 6 ESI-MS (m/z) observed: 617.1, calculated: 617.1 [M] -.
Synthesis of ProHance [Gd(HP-DO3A)(H 2 O)] (14)
To a 100 mL round bottom flask charged with a magnetic stir bar and tert-butyl DO3A • HBr (0.278 g, 0.47 mmol) was added 1:1 trifluoroacetic acid and dichloromethane (25 mL). Upon addition of the solvent/acid mixture, the reaction turned a pale orange, transparent color and was left to stir for 12 hours at room temperature. After such time, all solvent was evaporated resulting in a pale brown oil. 
Synthesis of Dotarem [Gd(DOTA)(H 2 O)] (15)
Unmetalated DOTA ligand was purchased from Macrocyclics, Inc., and was metalated using the same procedure as prior to generate 15.
Supplementary Figures
GO Characterization
All GO samples were characterized using atomic force microscopy (AFM), Raman spectroscopy, and X-ray photoelectron spectroscopy (XPS). AFM data for the 150 nm GO were reported previously, 7 while those for the 1500 nm GO are shown in Figure S1 . The mean and median of the sizes measured are summarized in Table S1 . The relatively consistent height of 0.85 nm across both the 150 nm GO and the 1500 nm GO indicates that these samples are predominantly single layer sheets.
Raman spectroscopy and XPS were used to probe the chemical structures of GO. Comparing the Raman spectra of the 1500 nm GO to the 150 nm GO, the larger sample showed an increase in the D band relative to the G band, and a broadening of the 2D and G+D band areas ( Figure S2 ). This result is similar to that observed for GO after solvothermal reduction 8 and that of graphene nanoribbons of increasing width. 9 Furthermore, XPS showed that the ratio of carbon-carbon bonds (C-C) to carbon- Figure  S3 ). The Raman and XPS data together indicate that the smaller GO bears fewer vacancy defects and 10%-15% more oxygen groups compared to the larger GO. That the smaller GO has comparatively more carbon-oxygen bonds than the larger GO may be explained by its larger edge-to-surface ratio. The edges of GO produced by the modified Hummers method are thought to be generously decorated with oxygen-containing functional groups.
10,11
Figure S1. a) Representative atomic force microscopy image of the 1500 nm GO. b) Distribution of the GO lateral size as characterized by square root of area. GO sheets from at least 5 separate areas were counted for a total of more than 150 sheets. 
Multiple Linear Regression Analysis
Multiple linear regression was used to construct a predictive model of the fold delivery enhancement achievable for small molecules when GO is used as a co-incubation vehicle. The result of regression found molecular adsorption, GO sedimentation, and GO size to be significant explanatory factors of delivery. Higher adsorption, faster sedimentation, and smaller GO size enhanced delivery. To ensure that this conclusion did not result from a violation of the assumptions of multiple linear regression, the r 2 change of adding and removing factors, and the p value and the variance inflation factor (VIF) of each explanatory variable were examined.
The r 2 examined were adjusted r 2 that take into account the spurious increase in r 2 when extra explanatory factors are added to a model. When the explanatory factors adsorption, size, and sedimentation were added in order into the model, the r 2 increased from 0.67 to 0.71 to 0.92. In the final 3-factor model, all of the factors had a p value < 10 -6 and a VIF < 10. Multiple linear regression assumes a lack of collinearity among the explanatory factors, and a VIF below 10 confirms that the assumption has not been violated. Together, these results indicate that adsorption, sedimentation, and size all independently contribute to the predictive power of the final linear model.
For further validation, predictions made by the model can be confirmed qualitatively. First, adsorption was observed to increase delivery even for molecules that did not induce additional sedimentation ( Figure S6 ). This result held true for both sizes of GO, confirming that adsorption correlates with delivery enhancement independent of sedimentation and size. Second, although 9 exhibited reduced adsorption compared to 12 (Figure 3a) , it achieved a fold delivery enhancement that matched or even surpassed 12 upon GO co-incubation (Figure 3c ). This result can be attributed to the increased GO sedimentation that 9 induced compared to 12, confirming that sedimentation has power in explaining delivery enhancement independent of adsorption. Third, given the same level of sedimentation and adsorption (e.g. 11 + 150 nm GO and 11 + 1500 nm GO), the 150 nm GO outperformed the 1500 nm GO in delivery, confirming that size is an independent predictor of delivery enhancement. Thus, the 3-factor multiple linear regression model of GO delivery enhancement is validated both qualitatively and statistically. Figure S6 . A significant correlation between delivery enhancement and adsorption can be found for molecules that did not increase GO sedimentation. The correlation was found for both the 150 nm and the 1500 nm GO. Adsorption predicts delivery enhancement independent of size and sedimentation. Error bars show SEM. Gray band shows 95% confidence interval. Figure 5c showed that both molecular adsorption and delivery enhancement were abolished when a Magnevist-150 nm GO mixture was added directly to media without allowing for adsorption time. The same result was found with a mixture of a) 10 + 1500 nm GO and b) Magnevist + 1500 nm GO. Experiments were performed with 188 μM Gd(III) concentration and 18.8 μg/mL GO incubation concentration. Error bars show SEM. 
Robustness of GO Co-incubation Protocol
The robustness of the GO co-incubation protocol was evaluated in terms of 1) generalizability across cell lines, 2) inherent variability, and 3) sensitivity to procedural parameters. Two molecular cargos, 10 and 12, were co-incubated with GO on KB and HeLa cells to assess the effect of cell line on GO delivery. The result showed similar delivery enhancement by GO regardless of the cell line used (Figure S9 ), suggesting that GO co-incubation is indeed a delivery strategy that can be generalized beyond HeLa cells.
To characterize the inherent variability of the co-incubation protocol, the coefficient of variation (%CV) was used to measure data spread. %CV is defined as the ratio of the standard deviation to the mean. Beyond experimental error, inherent data spread arises due to complexities in cellular behavior, serum components, and nanomaterial synthesis. At 35 mM [Magnevist] and 20 μg/mL [GO], Magnevist uptake with and without GO resulted in 515 ± 319 (62% CV over 17 trials) and 115 ± 32 (28% CV over 10 trials) fmol Gd/cell, respectively ( Figure S10 ). The increased variability observed with GO co-incubation may be attributed to varying degrees of GO sedimentation across multiple experiments. The Magnevist-GO combination would be particularly susceptible to this type of variability because it exhibited only moderate sedimentation in media (Figure 3b ), making it possible for environmental factors such as cellular secretions or uncontrolled serum components to further induce sedimentation and change delivery. For variability in nanomaterial synthesis, a 23% CV in cell uptake was observed across three batches of GO ( Figure S10) . Overall, the inherent variability found is smaller than the average delivery enhancement achieved with GO co-incubation. Therefore, while the degree of enhancement can vary from experiment to experiment, GO can consistently be expected to increase cellular delivery.
To characterize procedural robustness, variations were made to the standard cellular assay that used 25,000 cells per well in a 24-well plate with in-plate washing. From this baseline, it was found that increasing the cell density to 75,000 cells per well, assaying in a 6-well plate, and adding a centrifugation wash step lowered the cellular Gd(III) content by 53%, 39%, and 71%, respectively ( Figure S11) . Similarly, using GO concentrations higher than 20 μg/mL resulted in a decrease in delivery, likely due to the formation of flocculants and aggregates that can interfere with cellular interaction and entry ( Figure  S11 ). These procedural parameters evidently play a significant role in the GO co-incubation protocol and should not be overlooked in future experimental design.
As an example, cells used for MRI had lower Gd(III) contents compared to those from other studies due to a change in labeling vessel and the centrifugation step needed to control cell density. At 35 mM [Magnevist] and 20 μg/mL [GO], the typical cellular Gd(III) content was 299 ± 67 fmol/cell with GO (N=11) and 91 ± 9 fmol/cell without GO (N=4) (3.3x enhancement) ( Figure S10 ). In order to label a large number of cells for imaging, 6-well plates had to be used to replace the 24-well plates standard in the other studies. Moving from 24-well plates to 6-well plates decreased loading to 151 ± 56 fmol/cell with GO (N=13) and 49 ± 19 fmol/cell without GO (N=4) (3.1x enhancement). In order to control cell density for imaging, centrifugation was employed. The additional step resulted in the removal 60-70% of the Gd(III) labels, attributed to membrane binding ( Figure S11 ). In the imaging study, the loading achieved was 153 fmol/cell with GO and 69 fmol/cell without GO (2.2x enhancement) before centrifugation, and 47 fmol/cell with GO (69% label loss) and 30 fmol/cell without GO (57% label loss) after centrifugation. Figure S9 . The generalizability of GO co-incubation as a strategy to enhance cellular delivery was demonstrated in the KB cell line. Similar levels of delivery enhancement were achieved in KB compared to HeLa. This result generalized across 10 and Magnevist (12) for both the 150 nm and the 1500 nm GO. Experiments were performed with 188 μM Gd(III) concentration and 18.8 μg/mL GO incubation concentration. Error bars show SD for Gd content and SEM for delivery enhancement. Figure S12. Adsorption as characterized by measuring the amount of Gd left in the supernatant after the GO has been centrifuged into a pellet. These numbers are 30-1000 times greater than those measured directly from the pellet after washing. Direct measurement of adsorption on the GO pellet is considered to be the more reliable method of the two. The 150 nm GO was used for this experiment. 
